Immunogenicity 15319
Sample ID
patient3
Response
Negative
Tumor Type
Melanoma
Gene Symbol
HELLS
Transcript ID
None
HLA INFO
A*02:01
TCR INFO
No TCR info found!
Full length protein sequence (838 aa)
MPAER
1
PAGSG
6
GSEAP
11
AMVEQ
16
LDTAV
21
ITPAM
26
LEEEE
31
QLEAA
36
GLERE
41
RKMLE
46
KARMS
51
WDRES
56
TEIRY
61
RRLQH
66
LLEKS
71
NIYSK
76
FLLTK
81
MEQQQ
86
LEEQK
91
KKEKL
96
ERKKE
101
SLKVK
106
KGKNS
111
IDASE
116
EKPVM
121
RKKRG
126
REDES
131
YNISE
136
VMSKE
141
EILSV
146
AKKNK
151
KENED
156
ENSSS
161
TNLCV
166
EDLQK
171
NKDSN
176
SIIKD
181
RLSET
186
VRQNT
191
KFFFD
196
PVRKC
201
NGQPV
206
PFQQP
211
KHFTG
216
GVMRW
221
YQVEG
226
MEWLR
231
MLWEN
236
GINGI
241
LADEM
246
GLGKT
251
VQCIA
256
TIALM
261
IQRGV
266
PGPFL
271
VCGPL
276
STLPN
281
WMAEF
286
KRFTP
291
DIPTM
296
LYHGT
301
QEERQ
306
KLVRN
311
IYKRK
316
GTLQI
321
HPVVI
326
TSFEI
331
AMRDR
336
NALQH
341
CYWKY
346
LIVDE
351
GHRIK
356
NMKCR
361
LIREL
366
KRFNA
371
DNKLL
376
LTGTP
381
LQNNL
386
SELWS
391
LLNFL
396
LPDVF
401
DDLKS
406
FESWF
411
DITSL
416
SETAE
421
DIIAK
426
EREQN
431
VLHML
436
HQILT
441
PFLLR
446
RLKSD
451
VALEV
456
PPKRE
461
VVVYA
466
PLSKK
471
QEIFY
476
TAIVN
481
RTIAN
486
MFGSS
491
EKETI
496
ELSPT
501
GRPKR
506
RTRKS
511
INYSK
516
IDDFP
521
NELEK
526
LISQI
531
QPEVD
536
RERAV
541
VEVNI
546
PVESE
551
VNLKL
556
QNIMM
561
LLRKC
566
CNHPY
571
LIEYP
576
IDPVT
581
QEFKI
586
DEELV
591
TNSGK
596
FLILD
601
RMLPE
606
LKKRG
611
HKVLL
616
FSQMT
621
SMLDI
626
LMDYC
631
HLRDF
636
NFSRL
641
DGSMS
646
YSERE
651
KNMHS
656
FNTDP
661
EVFIF
666
LVSTR
671
AGGLG
676
INLTA
681
ADTVI
686
IYDSD
691
WNPQS
696
DLQAQ
701
DRCHR
706
IGQTK
711
PVVVY
716
RLVTA
721
NTIDQ
726
KIVER
731
AAAKR
736
KLEKL
741
IIHKN
746
HFKGG
751
QSGLN
756
LSKNF
761
LDPKE
766
LMELL
771
KSRDY
776
EREIK
781
GSREK
786
VISDK
791
DLELL
796
LDRSD
801
LIDQM
806
NASGP
811
IKEKM
816
GIFKI
821
LENSE
826
DSSPE
831
CLF
836
Mutation Information
DNA mutation:
None
Peptide Range:
595 ~ 603
Mut AA position:
597 (3 in Wild Type peptide)
Alignment
Wild Type:
"VTNSGKFLI
||.||||||
Mutant:
VTYSGKFLI"
Science, 2016
Targeting of cancer neoantigens with donor-derived T cell receptor repertoiresGene Name (from Reference) HELLS
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
MoDCs
Assay
IFNg ELISPOT assay